Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease
2010 · New England Journal of Medicine · 886 citations
https://doi.org/10.1056/nejmoa0910496
A
Ali A. Rizvi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
226
Papers
6.9K
Citations
45
h-index
109
i10-index
Ali A. Rizvi is an academic researcher from International Institute for Population Sciences. The author has contributed to research in topics: Diabetes Treatment and Management & Diabetes Management and Research & Diabetes, Cardiovascular Risks, and Lipoproteins. The author has an h-index of 45, co-authored 193 publications.
ORCID: 0000-0002-3714-0790Papers by this author
worksLiraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
2014 · Cardiovascular Diabetology · 107 citations
https://doi.org/10.1186/1475-2840-13-49
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
2020 · Diabetes Therapy · 70 citations
https://doi.org/10.1007/s13300-020-00962-3
Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer
2003 · Pathology & Oncology Research · 31 citations
https://doi.org/10.1007/bf02893382
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
2023 · Diabetes Therapy · 16 citations
https://doi.org/10.1007/s13300-023-01465-7
Dapagliflozin therapy in type-2 diabetes: current knowledge and future perspectives
2014 · Expert Opinion on Pharmacotherapy · 8 citations
https://doi.org/10.1517/14656566.2015.981528
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat